The authors regret that the acknowledgements section of the published paper was incomplete and should include the following statement:
Raquel Vivet-Noguer was supported by the Institut Curie 3-i PhD Program under Marie Skłodowska-Curie Grant Agreement No 666003.
The authors would like to apologise for any inconvenience caused.
Published online: February 27, 2023
Publication stageIn Press Corrected Proof
© 2023 The Author(s). Published by Elsevier Ltd. All rights reserved.
ScienceDirectAccess this article on ScienceDirect
- Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanomaEuropean Journal of CancerVol. 126Open Access